Literature DB >> 29147957

Mobilization of endothelial progenitor cell in patients with acute ischemic stroke.

Yushuang Deng1, Jian Wang1, Guiqiong He2, Fei Qu3, Min Zheng4.   

Abstract

Endothelial progenitor cells (EPCs) have important effect in tissue repair in ischemic organs. The present study was conducted to demonstrate the mobilization of EPCs and its possible mechanism after acute ischemic stroke (AIS). A total of 148 individuals were examined, including 106 patients with ischemic stroke and 42 healthy controls. Seventy-one patients with imaging-confirmed AIS were examined at days 1, 7, 14, and 21 after stroke onset. Circulating EPCs were quantified by flow cytometry using CD133 and KDR surface markers. Serum stromal cell-derived factor-1 (SDF-1) concentrations were determined by enzyme-linked immunosorbent assay. Patients with AIS had significantly lower EPC level than that in the controls (0.022 ± 0.013 vs 0.051 ± 0.020; p < 0.01). This difference did not remain significant after adjusting for risk factors at multivariate analysis. Blood pressure, triglyceride, low-density lipoprotein (LDL), and fasting blood sugar were inversely correlated with EPC levels (p < 0.01). Systolic blood pressure and LDL remained independent predictors of baseline EPC levels. The number of circulating EPCs increased on day 7 after AIS, reached a peak on day 14, and decreased on day 21. The concentration of SDF-1 had similar changes. The increment of EPCs was correlated with the infarct volume (r = 0.708; p = 0.006) and SDF-1 concentration on day 14 (r = 0.714; p < 0.001). Baseline EPC level in patients with AIS reflects the cumulative vascular endothelial damage. EPCs could be mobilized into peripheral circulation in response to stroke stress. This mobilization was associated with the increased expression of SDF-1.

Entities:  

Keywords:  Acute ischemic stroke; Endothelial progenitor cells; Mobilization; Stromal cell-derived factor-1

Mesh:

Substances:

Year:  2017        PMID: 29147957     DOI: 10.1007/s10072-017-3143-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  24 in total

Review 1.  Modulation of the SDF-1-CXCR4 axis by the third complement component (C3)--implications for trafficking of CXCR4+ stem cells.

Authors:  Marius Z Ratajczak; Ryan Reca; Marcin Wysoczynski; Jun Yan; Janina Ratajczak
Journal:  Exp Hematol       Date:  2006-08       Impact factor: 3.084

2.  Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke.

Authors:  Hon-Kan Yip; Li-Teh Chang; Wen-Neng Chang; Cheng-Hsien Lu; Chia-Wei Liou; Min-Yu Lan; Josef S Liu; Ali A Youssef; Hsueh-Wen Chang
Journal:  Stroke       Date:  2007-12-06       Impact factor: 7.914

3.  Endothelial progenitor cell transplantation improves long-term stroke outcome in mice.

Authors:  Yongfeng Fan; Fanxia Shen; Tim Frenzel; Wei Zhu; Jianqin Ye; Jianrong Liu; Yongmei Chen; Hua Su; William L Young; Guo-Yuan Yang
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

4.  Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair.

Authors:  Caroline Schmidt-Lucke; Lothar Rössig; Stephan Fichtlscherer; Mariuca Vasa; Martina Britten; Ulrike Kämper; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

5.  Isolation of putative progenitor endothelial cells for angiogenesis.

Authors:  T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

6.  Decreased levels and function of circulating endothelial progenitor cells in unruptured intracranial saccular aneurysm patients.

Authors:  Chong Liang; Hao Feng; Ben-Qiang Deng; Zi-Fu Li; Qing-Hai Huang; Wei Zhao; Wen-Yuan Zhao; Peng-Fei Yang; Yi Xu; Rui Zhao; Jian-Min Liu
Journal:  Neurol Sci       Date:  2013-05-24       Impact factor: 3.307

7.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

Review 8.  The role of endothelial progenitor cells in ischemic cerebral and heart diseases.

Authors:  Dah-Ching Ding; Woei-Cherng Shyu; Shinn-Zong Lin; Hung Li
Journal:  Cell Transplant       Date:  2007       Impact factor: 4.064

Review 9.  Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells.

Authors:  Yuji Kaneko; Naoki Tajiri; Kazutaka Shinozuka; Loren E Glover; Nathan L Weinbren; Lourdes Cortes; Cesar V Borlongan
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

10.  The role of endothelial progenitor cells in transient ischemic attack patients for future cerebrovascular events.

Authors:  Rokhsareh Meamar; Hamidreza Nikyar; Leila Dehghani; Maedeh Talebi; Marzieh Dehghani; Marzieh Ghasemi; Behnaz Ansari; Mohammad Saadatnia
Journal:  J Res Med Sci       Date:  2016-06-14       Impact factor: 1.852

View more
  8 in total

Review 1.  Neovascularization and tissue regeneration by endothelial progenitor cells in ischemic stroke.

Authors:  Ji Li; Yan Ma; Xiao-Hui Miao; Ji-Dong Guo; Da-Wei Li
Journal:  Neurol Sci       Date:  2021-07-03       Impact factor: 3.307

2.  Influence of metabolic syndrome on post-stroke outcome, angiogenesis and vascular function in old rats determined by dynamic contrast enhanced MRI.

Authors:  Jesús M Pradillo; Macarena Hernández-Jiménez; María E Fernández-Valle; Violeta Medina; Juan E Ortuño; Stuart M Allan; Spencer D Proctor; Juan M Garcia-Segura; María J Ledesma-Carbayo; Andrés Santos; María A Moro; Ignacio Lizasoain
Journal:  J Cereb Blood Flow Metab       Date:  2020-12-01       Impact factor: 6.200

3.  The Nlrp3 Inflammasome Orchestrates Mobilization of Bone Marrow-Residing Stem Cells into Peripheral Blood.

Authors:  Anna M Lenkiewicz; Mateusz Adamiak; Arjun Thapa; Kamila Bujko; Daniel Pedziwiatr; Ahmed K Abdel-Latif; Magda Kucia; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

4.  Dietary Supplemental Glutamine Enhances the Percentage of Circulating Endothelial Progenitor Cells in Mice with High-Fat Diet-Induced Obesity Subjected to Hind Limb Ischemia.

Authors:  Chi-Hsuan Ko; Sung-Ling Yeh; Chiu-Li Yeh
Journal:  Mediators Inflamm       Date:  2020-02-13       Impact factor: 4.711

Review 5.  Unraveling the potential of endothelial progenitor cells as a treatment following ischemic stroke.

Authors:  Antía Custodia; Alberto Ouro; João Sargento-Freitas; Marta Aramburu-Núñez; Juan Manuel Pías-Peleteiro; Pablo Hervella; Anna Rosell; Lino Ferreira; José Castillo; Daniel Romaus-Sanjurjo; Tomás Sobrino
Journal:  Front Neurol       Date:  2022-09-08       Impact factor: 4.086

6.  The Inhibition of CD39 and CD73 Cell Surface Ectonucleotidases by Small Molecular Inhibitors Enhances the Mobilization of Bone Marrow Residing Stem Cells by Decreasing the Extracellular Level of Adenosine.

Authors:  Mateusz Adamiak; Kamila Bujko; Katarzyna Brzezniakiewicz-Janus; Magda Kucia; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

7.  Using mRNA deep sequencing to analyze differentially expressed genes during Panax notoginseng saponin treatment of ischemic stroke.

Authors:  Jun Lin; Ping Liang; Qing Huang; Chongdong Jian; Jianmin Huang; Xionglin Tang; Xuebin Li; Yanling Liao; Xiaohua Huang; Wenhua Huang; Li Su; Lanqing Meng
Journal:  Mol Med Rep       Date:  2020-09-29       Impact factor: 2.952

8.  Construction and a preliminary study of paracrine effect of bone marrow-derived endothelial progenitor cell sheet.

Authors:  Fenlong Xue; Yunpeng Bai; Yiyao Jiang; Jianshi Liu; Kaitao Jian
Journal:  Cell Tissue Bank       Date:  2021-05-30       Impact factor: 1.522

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.